TipRanks
Sunshine Biopharma (SBFM)
NASDAQ:SBFM
US Market
SBFM
Sunshine Biopharma
RESEARCH TOOLSreports
Want to see SBFM full AI Analyst Report?

Sunshine Biopharma (SBFM) Income Statement

487 Followers

Sunshine Biopharma Income Statement

Last quarter (Q2 2026), Sunshine Biopharma's total revenue was $9.26M, a decrease of -1.56% from the same quarter last year. In Q2, Sunshine Biopharma's net income was $-1.56M. See Sunshine Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Mar 24Mar 23Dec 21
Total Revenue
$ 36.31M$ 34.87M$ 24.09M$ 4.35M$ 228.43K
Gross Profit
$ 11.92M$ 10.67M$ 8.34M$ 1.70M$ 110.60K
Operating Expenses
$ 16.40M$ 16.48M$ 13.12M$ 10.37M$ 2.55M
Depreciation and Amortization
$ 332.07K$ 223.53K$ 149.15K$ 25.16K$ 12.74K
EBITDA
$ -5.62M$ -5.14M$ -3.82M$ -26.45M$ -12.09M
Operating Income
$ -4.48M$ -5.81M$ -4.79M$ -8.67M$ -2.44M
Other Income/Expenses
$ -1.47M$ 443.15K$ 674.42K$ -17.84M$ -10.00M
Pretax Income
$ -5.95M$ -5.37M$ -4.11M$ -26.51M$ -12.44M
Net Income
$ -5.98M$ -5.13M$ -4.51M$ -26.74M$ -12.44M
Per Share Metrics
Basic EPS
$ -14.40$ -73.20$ -3.51K$ -35.24K$ -97.74K
Diluted EPS
$ -14.40$ -73.20$ -3.51K$ -35.24K$ -95.20K
Weighted Average Shares Outstanding
 415.71K 70.17K 1.22K 759.00 131.00
Weighted Average Shares Outstanding (Diluted)
 415.71K 70.17K 1.22K 759.00 131.00
Currency in USD

Sunshine Biopharma Earnings and Revenue History